Acadia Healthcare(US:ACHC)2026-02-25 15:02Financial Data and Key Metrics Changes - The company reported revenue of $821.5 million for Q4 2025, a 6.1% increase year-over-year [14] - Full year 2025 revenue reached $3.31 billion, reflecting a 5% increase over the prior year [15] - Adjusted EBITDA for Q4 was $99.8 million, with full year adjusted EBITDA at $608.9 million, near the upper end of guidance [15][16] - Same-facility revenue grew 4.4% year-over-year, driven by a 1.3% increase in revenue per patient day and a 3.1% increase in patient days [16] Business Line Data and Key Metrics Changes - The company added 181 beds in Q4 2025, totaling 1,089 beds added for the full year, exceeding guidance [17][18] - Startup losses related to newly opened facilities were $12.8 million in Q4, compared to $11.2 million in Q4 2024 [16] - The company plans to add between 400 and 600 new beds in 2026, primarily through new facilities [18] Market Data and Key Metrics Changes - The company is facing a $25 million-$30 million annual EBITDA impact due to New York's decision to limit Medicaid patients to in-state facilities [21][72] - The company anticipates a 2%-3% increase in same facility revenue per patient day for 2026, despite a decrease in Medicaid supplemental payment revenue [20] Company Strategy and Development Direction - The focus is on operational excellence and execution, with a commitment to support teams in the field [5][10] - The company is evaluating service lines comprehensively to ensure alignment with long-term value creation [11] - There is a strong emphasis on quality and patient safety, with a commitment to improve operational discipline and management quality [8][12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strong demand for behavioral health services and the company's ability to meet that need [10][24] - The company expects full year 2026 revenue to be between $3.37 billion and $3.45 billion, with adjusted EBITDA of $575 million-$610 million [19] - Management acknowledged challenges in the operating environment but remains optimistic about unlocking EBITDA and free cash flow potential [10][24] Other Important Information - The company invested $93 million in CapEx in Q4 2025, totaling $572 million for the full year, which was nearly $50 million favorable to prior guidance [17] - The company is focused on improving relationships with referral sources and enhancing operational performance at the facility level [53] Q&A Session Summary Question: Status of the value creation review with outside advisors - Management confirmed that the review is ongoing and focused on immediate progress while also looking for long-term value opportunities [27][28] Question: Growth algorithm expectations in the current environment - Management believes the growth algorithm remains unchanged, with strong demand expected to continue [30] Question: Timeframe for realizing embedded earnings from development activity - Management indicated that the realization of the $200 million incremental EBITDA opportunity is expected within five years [35] Question: Addressing pressure on average length of stay from managed Medicaid - Management stated that they maintain stable length of stay and advocate for patients to ensure appropriate care [42] Question: Plans to rebuild trust with referral sources - Management emphasized the importance of delivering high-quality care consistently to rebuild trust with referral sources [52] Question: Long-term CapEx strategy - Management indicated a focus on improving existing facilities and being disciplined with capital expenditures moving forward [60][62] Question: Impact of California's new staffing requirements - Management expects a $4 million EBITDA impact from new staffing guidelines, which is embedded in guidance [78] Question: Observations on the ramp of new facilities - Management noted that the ramping of new facilities is being assessed on a case-by-case basis, with plans to improve processes for future openings [85]